{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:23:14Z","timestamp":1773354194893,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.intimp.2020.106462","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T05:46:01Z","timestamp":1585892761000},"page":"106462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A"],"prefix":"10.1016","volume":"83","author":[{"given":"Jie","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Shirozu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukie","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.106462_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.intimp.2016.03.040","article-title":"Augmenter of liver regeneration (ALR) restrains concanavalin A-induced hepatitis in mice","volume":"35","author":"Mu","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106462_b0010","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.106462_b0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.106462_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.106462_b0025","first-page":"1323","article-title":"Lupoid hepatitis","volume":"271","author":"Cowling","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.106462_b0030","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013Update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2020.106462_b0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.106462_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrgastro.2016.193","article-title":"Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches","volume":"14","author":"Sapisochin","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2020.106462_b0045","first-page":"567","article-title":"Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2020.106462_b0050","first-page":"2757","article-title":"Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2020.106462_b0055","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1182\/blood-2007-08-106005","article-title":"Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity","volume":"110","author":"Zeiser","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106462_b0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","article-title":"Isoprenoids determine Th1\/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin","volume":"203","author":"Dunn","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106462_b0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1517\/13543781003801076","article-title":"Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib","volume":"19","author":"Epling-Burnette","year":"2010","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.intimp.2020.106462_b0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00280-012-1972-1","article-title":"Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2\/neu overexpressing breast cancer: EORTC study 16023","volume":"71","author":"Milojkovic Kerklaan","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106462_b0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10620-011-1880-y","article-title":"Prevention of induced colitis in mice by the ras antagonist farnesylthiosalicylic acid","volume":"57","author":"Oron","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2020.106462_b0080","article-title":"Small GTPase RAS in multiple sclerosis - exploring the role of RAS GTPase in the etiology of multiple sclerosis","volume":"GTPases:1","author":"Messina","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.intimp.2020.106462_b0085","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","article-title":"Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)","volume":"126","author":"Katzav","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0090","first-page":"1314","article-title":"Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir\/ritonavir)-induced lipodystrophy and metabolic syndrome in mice","volume":"15","author":"Tanaka","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2020.106462_b0095","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fimmu.2017.00799","article-title":"Ras signaling inhibitors attenuate disease in adjuvant-induced arthritis via targeting pathogenic antigen-specific Th17-type cells","volume":"8","author":"Zayoud","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2010.06.029","article-title":"Ras inhibition attenuates pancreatic cell death and experimental type 1 diabetes: possible role of regulatory T cells","volume":"643","author":"Aizman","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106462_b0105","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/MCB.21.5.1444-1452.2001","article-title":"Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development","volume":"21","author":"Esteban","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2020.106462_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3748\/wjg.v18.i2.119","article-title":"Immune mechanisms of Concanavalin A model of autoimmune hepatitis","volume":"18","author":"Wang","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2020.106462_b0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.106462_b0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.191.1.105","article-title":"Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis","volume":"191","author":"Kaneko","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.106462_b0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/SHK.0000000000000239","article-title":"Farnesyltransferase inhibitor, tipifarnib, prevents galactosamine\/lipopolysaccharide-induced acute liver failure","volume":"42","author":"Shirozu","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.intimp.2020.106462_b0130","first-page":"17","article-title":"Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis","volume":"50","author":"Eggink","year":"1982","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0135","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.167.1.514","article-title":"Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure","volume":"167","author":"Streetz","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0140","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.159.3.1418","article-title":"Suppression of concanavalin A-induced hepatitis in IFN-gamma(-\/-) mice, but not in TNF-alpha(-\/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes","volume":"159","author":"Tagawa","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0145","doi-asserted-by":"crossref","first-page":"7504521","DOI":"10.1155\/2020\/7504521","article-title":"The role of serotonin in concanavalin A-induced liver injury in mice","volume":"2020","author":"Pang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.intimp.2020.106462_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106137","article-title":"Demethyleneberberine attenuates concanavalin A-induced autoimmune hepatitis in mice through inhibition of NF-kappaB and MAPK signaling","volume":"80","author":"Zhang","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106462_b0155","doi-asserted-by":"crossref","first-page":"G1044","DOI":"10.1152\/ajpgi.00184.2004","article-title":"IFN-gamma\/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1","volume":"287","author":"Jaruga","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2020.106462_b0160","first-page":"1615","article-title":"Mice deficient for N-ras: impaired antiviral immune response and T-cell function","volume":"63","author":"Perez de Castro","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2020.106462_b0165","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1101\/gad.11.19.2468","article-title":"K-ras is an essential gene in the mouse with partial functional overlap with N-ras","volume":"11","author":"Johnson","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.intimp.2020.106462_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/jhep.2001.21162","article-title":"Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection","volume":"33","author":"Chang","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2020.106462_b0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"Kusters","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2020.106462_b0180","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS","volume":"110","author":"Hong","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2020.106462_b0185","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/sj.leu.2402629","article-title":"Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells","volume":"16","author":"Le Gouill","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2020.106462_b0190","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1159\/000489074","article-title":"Comparison of concanavalin a-induced murine autoimmune hepatitis models","volume":"46","author":"Ye","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2020.106462_b0195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.coi.2013.09.008","article-title":"Natural killer T (NKT) cells in autoimmune hepatitis","volume":"25","author":"Mattner","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0200","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1124\/jpet.111.183558","article-title":"Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance","volume":"339","author":"Yang","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2020.106462_b0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3324\/haematol.2012.065789","article-title":"Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells","volume":"98","author":"Hechinger","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2020.106462_b0210","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1182\/blood-2006-06-031088","article-title":"Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level","volume":"110","author":"Marks","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.106462_b0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trim.2008.09.011","article-title":"Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors","volume":"20","author":"Gaylo","year":"2009","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.intimp.2020.106462_b0220","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2020.106462_b0225","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep4.1202","article-title":"Immune alterations in patients with type 1 autoimmune hepatitis persist upon standard immunosuppressive treatment","volume":"2","author":"Renand","year":"2018","journal-title":"Hepatol.. Commun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920304422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920304422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:24:09Z","timestamp":1761585849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920304422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":45,"alternative-id":["S1567576920304422"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106462","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The farnesyltransferase inhibitor tipifarnib protects against autoimmune hepatitis induced by Concanavalin A","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106462"}}